Abstract
The anti-Hu antibody (HuAb) is directed against RNA-associated neuronal proteins and is known to cause paraneoplastic encephalomyelitis/sensory neuronopathy syndrome mostly when associated with small cell lung cancer (SCLC). Paraneoplastic encephalomyelitis/sensory neuronopathy syndrome with concurrent autonomic neuropathy has been reported to occur in paraneoplastic syndromes, although its occurrence concomitant with acute pandysautonomia is less frequent. The authors describe the clinical, neuropathologic, and serologic features of two cases with an anti-Hu-related paraneoplastic syndrome presenting with progressive autonomic neuropathy. Both patients showed features of dysautonomia, including postural dizziness, abdominal pain, and diarrhea, and symptoms of sensory neuropathy. Investigations disclosed severe sensory and autonomic neuropathy and positive HuAb titers. The disease of patient 1 had a very rapid progression, and the patient died of cardiac arrest within 2 months of the onset of symptoms. The autopsy revealed SCLC. In contrast, the disease of patient 2 had a less aggressive course. An extensive tumor search disclosed SCLC only 28 months after onset of symptoms, and the patient died 1 month later of cardiorespiratory arrest. Autopsies in both cases showed inflammation involving the intermediolateral columns and the dorsal root ganglia. These two cases illustrate the association of early dysautonomia with HuAb-related paraneoplastic syndrome and the variations of clinical, neuropathologic, and serologic findings in these types of cases.
Similar content being viewed by others
References
King PH, Dropcho EJ. Expression of Hel-N1 and Hel-N2 in small-cell lung carcinoma.Ann Neurol 1996; 39:679–681.
Manley GT, Smitt PS, Dalamau J, et al. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites.Ann Neurol 1995; 38:102–110.
Posner JB, Paraneoplastic syndromes. In:Neurology in clinical practice. WG Bradley, Daroff RB, Fenichel GM, et al. eds. Boston: Butterworth-Heinemann; 1996. pp. 1165–1172.
Dalmau J, Graus F, Rosenblum MK, et al. Anti-Hu associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients.Medicine 1992; 71:59–72.
Lennon VA, Sas DF, Busk MF, et al. Enteric neuronal antoantibodies in pseudoobstruction with small-cell lung carcinoma.Gastroenterology 1991; 100:137–142.
Graus F, Bonaventura I, Uchuya M, et al. Indolent anti-Hu associated paraneoplastic sensory neuropathy.Neurology 1994; 44: 2258–2261.
Ichimura M, Yamamoto M, Kobayashi O, et al. Tissue distribution of pathological lesions and Hu antigen expression in paraneoplastic sensory neuronopathy.Acta Neuropathol 1998; 95:641–648.
Vernino S, Adamski J, Kryzer TJ, et al. Neuronal nicotinic ACH receptor antibody in subacute autonomic neuropathy and cancer-related syndromes.Neurology 1998; 50:1806–1813.
Voltz RD. Paraneoplastic encephalomyelitis: an update of the effects of the anti-Hu immune response on the nervous system and tumour.J Neurol Neurosurg Psychiatry 1997; 63:133–136
Blaes F. Cytotoxicity to myenteric plexus in paraneoplastic neurological syndromes is IgG-mediated [abstract].Clin Auton Res 1998; 8:51.
Rosenblum MK. Paraneoplasia and autoimmunologic injury of the nervous system: the anti-Hu syndrome.Brain Pathol 1993; 3:199–212.
Chartrand-Lefebre C, Howarth N, Grenier P, et al. Association of small cell lung cancer and the anti-Hu paraneoplastic syndrome: radiographic and CT findings.Am J Roentgenol 1998; 170:1513–1517.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Winkler, AS., Dean, A., Hu, M. et al. Phenotypic and neuropathologic heterogeneity of anti-Hu antibody-related paraneoplastic syndrome presenting with progressive dysautonomia: report of two cases. Clinical Autonomic Research 11, 115–118 (2001). https://doi.org/10.1007/BF02322055
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02322055